Platform Session

[EO-11] Platform Session 11：Neurometabolic Disorders 2

Fri. Jun 3, 2022 3:30 PM - 4:10 PM Room 6 (Medium Conference Room 202)

Chair: Specchio Nicola(Department of Neuroscience Bambino Ges Children's)

+Add all to schedule

[EO-054] Iron Metabolism in SENDA／BPAN, an Autophagy Disease Due to WDR45 Variants

Kiwako Tsukida，Kazuhiro Muramatsu，Takanori Yamagata (Jichi Medical University)

[EO-055] Neuronal cell pathology from induced pluripotent stem cells of Fabry disease and Niemann Pick C

Yoshikatsu Eto，Takashi Miyajima，Miki Igarashi，Ryo Saito (Southern Tohoku Institute of Neuroscience, Kawasaki, Japan)

[EO-056] Long—term efficacy of gene therapy for AADC deficiency using AAV2—AADC vector

Karin Kojima¹，Akihiko Miyauchi¹，Takahiro Ikeda¹，Yoshie Kurokawa¹，Yoshiyuki Onuki²，Takeshi Nakajima²，Masahiro Hirai^1,5，Kazuhiro Muramatsu¹，Hitoshi Osaka¹，Shin—Ichi Muramatsu^3,4，Takanori Yamagata¹ (1. Department of Pediatrics, Jichi Medical University, Shimotsuke, Tochigi, Japan，2. Department of Neurosurgery, Jichi Medical University, Shimotsuke, Tochigi, Japan，3. Division of Neurological Gene Therapy, Center for Open Innovation, Jichi Medical University, Shimotsuke, Tochigi, Japan，4. Center for Gene and Cell therapy, The instirute of medical science, The University of Tokyo, Tokyo, Japan，5. Department of Cognitive and Psychological Sciences, Graduate School of Informatics, Nagoya University, Nagoya, Aichi, Japan)

[EO-057] The effect of valproate for carnitine serum concentration in epilepsy patients

Noboru Yoshida¹，Toshiaki Shimizu² (1. Juntendo University Nerima Hospital，2. Department of Pediatrics, Juntendo University Faculy of Medicine, Tokyo, Japan)